HGH Holdings Ltd.

Equities

5GZ

SG1S12926576

Construction Materials

Delayed Singapore S.E. 04:07:15 2024-04-11 am EDT 5-day change 1st Jan Change
0.012 SGD +9.09% Intraday chart for HGH Holdings Ltd. +9.09% +9.09%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
HGH Holdings Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
HGH Holdings Ltd. Announces Board and Committee Changes CI
Ascendis Pharma Signs Distribution Deals With Vector Pharma, Specialised Therapeutics; Introduces Vision 2030 MT
Heartland Group Lowers Financial Year 2024 Guidance MT
Ascendis Pharma Signs Exclusive License Deal With Japan's Teijin MT
HGH Holdings Trims Losses in January-June MT
HGH Holdings Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Australia Shares Decline on Friday; Heartland Slips MT
Heartland Group Closes Subordinated Bonds Offer MT
HGH Holdings Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Challenger Signs Deal to Sell Banking Subsidiary to Heartland; Shares Rise 4% MT
Heartland Group Completes Share Sale, Raises Nearly $42 Million MT
Heartland Group Raises $81 Million Via Share Placement MT
HGH Holdings Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Elders Completes Divestiture of 30% Stake in Livestock Company StockCo 2 Holdings MT
Heartland Group Holdings Completes Purchase of StockCo Australia MT
Heartland Group Taps Heartland Bank CEO for Deputy Group CEO Role MT
Heartland Group Subsidiary Completes Senior Unsecured Bond Issuance of $72.2 Million MT
Fitch Revises Heartland's Outlook to Negative from Stable MT
Heartland Group Acquiring Livestock Business for $107 Million MT
Ascendis Pharma Prices $500 Million Offering in Convertible Notes MT
HGH Holdings Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
HGH Holdings Ltd. Announces Termination of Memorandum of Understanding with AAEX Pte. Ltd CI
Ascendis Pharma's Growth Hormone Drug TransCon hGH Gets EU Approval MT
Ascendis Pharma Says EMA Panel Issues Positive Opinion Backing Approval of Growth Hormone Deficiency Drug MT
Chart HGH Holdings Ltd.
More charts
HGH Holdings Ltd. is a Singapore-based investment holding company. The Company’s segments include Leasing and service income, Manufacturing of precast concrete products, Supply and manufacturing of ready-mix concrete products, Provision of underground cable installation and road reinstatement, and Corporate. Leasing and service income provides general warehousing and logistics services, industrial and office space for engineering, manufacturing, industrial training and workers’ dormitory facilities. It supplies ready-mix concrete in Singapore to customers in the construction and civil engineering sector through its Supply and manufacturing of ready-mix concrete products segment. The Manufacturing of precast concrete products provides structural and non-structural precast concrete products. Underground cable installation refers to the installation of power cables, and auxiliary cables under the ground. Road reinstatement refers to the backfilling and reinstatement of road surfaces.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 5GZ Stock
  4. News HGH Holdings Ltd.
  5. Singapore Shares Close Lower; HGH Balloons 113% on Signing MoU to Establish Blockchain Platform